Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphaneReza Bayat Mokhtari(European Automobile Manufacturers Association), Herman Yeger(University of Toronto)BMC CancerAugust 30, 201910.1186/s12885-019-6018-1Cited by 17SaveCiteExport RISWatch citationsRelated PapersHypoxia Enhances Tumor Stemness by Increasing the Invasive and Tumorigenic Side Population Fraction|Stem Cells|2008|305Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma|BMC Cancer|2017|46Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis|Oncotarget|2021|23